SCHEMBL19913148

SCHEMBL19913148

N#Cc1cc(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)c(-c2ccncc2)c(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.35
CSNK1A1 P48729 1/20 0.34
CSNK1D P48730 1/20 0.34
SLC6A2 P23975 1/20 0.34
BRAF P15056 1/20 0.34
KDR P35968 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
PTGER4 P35408 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
MET P08581 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
FLT3 P36888 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913155 1.00 MAPK14 (0.35) MAPK14CSNK1A1CSNK1DSLC6A2BRAF
SCHEMBL19913143 0.93 MAPK14 (0.35) MAPK14CSNK1A1CSNK1DSLC6A2BRAF
SCHEMBL19913141 0.93 MAPK14 (0.35) MAPK14CSNK1A1CSNK1DSLC6A2BRAF
SCHEMBL21757798 0.91 MAPK14 (0.40) MAPK14CSNK1A1CSNK1DSLC6A2ABCG2
SCHEMBL19909037 0.90 MAPK14 (0.38) MAPK14CSNK1A1CSNK1DSLC6A2ABCG2
SCHEMBL21414191 0.88 KDM4E (0.37) KDM4EATML3MBTL1PTGER4HPGD
SCHEMBL21414189 0.88 KDM4E (0.37) KDM4EATML3MBTL1PTGER4HPGD
SCHEMBL19913139 0.87 MAPK14 (0.37) MAPK14CSNK1A1CSNK1DSLC6A2KDM4E
SCHEMBL19909114 0.87 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DSLC6A2ABCG2
SCHEMBL19908925 0.87 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DSLC6A2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CSNK1A1 4231/4885CSNK1D 3662/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 MAPK14 2787/4885CSNK1A1 2962/4885CSNK1D 1514/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CSNK1A1 4231/4885CSNK1D 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.